Altre lingue Ganga Pharmaceuticals Limited

Azioni

GANGAPHARM6

INE615T01017

Mercato chiuso - Bombay S.E. Altri mercati azionari 12:00:55 24/06/2024			Variaz. 5gg	Var. 1 gen.
24,67 ^INR	-.--%		-.--%	-13,41%

16/05	Ganga Pharmaceuticals Limited riporta i risultati degli utili per l'intero anno terminato il 31 marzo 2024	CI
2023	Ganga Pharmaceuticals Limited riporta i risultati degli utili per il semestre conclusosi il 30 settembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Ganga Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024	16/05
Ganga Pharmaceuticals Limited announced that it has received INR 17.0625 million in funding from Lenus Finvest Pvt Ltd, Plutus Capital Management Llp	19/01
Ganga Pharmaceuticals Limited announced that it expects to receive INR 21 million in funding from Lenus Finvest Pvt Ltd, Plutus Capital Management Llp	04/12
Ganga Pharmaceuticals Board to Consider Issuing Equity, Convertible Warrants to Raise Funds	27/11
Ganga Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended September 30, 2023	08/11
Ganga Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2023	22/08/23
Ganga Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended September 30, 2022	11/11/22
Ganga Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2022	25/05/22
Ganga Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2021	28/06/21
Ganga Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended September 30, 2020	05/11/20
Ganga Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2020	27/06/20
Ganga Pharmaceuticals Limited Announces Management Changes	25/05/20
Ganga Pharmaceuticals Limited Announces the Appointment and Re-Designation of Sanjay Kulkarni as Executive Director	27/08/19
Ganga Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2019	13/05/19
874,550 equity shares of Ganga Pharmaceuticals Limited are subject to a Lock-Up Agreement Ending on 23-FEB-2019.	23/02/19
Ganga Pharmaceuticals Limited Reports Unaudited Standalone Earnings Results for the Half Year Ended September 30, 2018	05/11/18
Ganga Pharmaceuticals Limited Appoints Anagh B. Sharma as Chief Financial Officer	06/09/18
Ganga Pharmaceuticals Limited Announces Resignation of Ganesh Jyothimani Paradeshi, Chief Financial Officer	30/08/18
Ganga Pharmaceuticals Limited Announces Audited Standalone Earnings Results for the Half Year and Full Year Ended March 31, 2018	28/05/18
Ganga Pharmaceuticals Limited Reports Unaudited Standalone Earnings Results for the Half Year Ended September 30, 2017	09/11/17

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Ganga Pharmaceuticals Limited

Azioni

GANGAPHARM6

INE615T01017

Altre lingue

Filtri